시간 외 거래: 3.61 0.010 +0.28%

Pyxis Oncology Inc (PYXS)

Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스

Pyxis Oncology Inc (PYXS)

Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스

Moment Of Truth Approaches For Pyxis Oncology (NASDAQ:PYXS) - Seeking Alpha

Pyxis Oncology : Morgan Stanley 22nd Annual Global Healthcare Conference - Marketscreener.com

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - SETE News

Have you been able to find a good deal on Pyxis Oncology Inc’s shares? - US Post News

Quarterly Snapshot: Quick and Current Ratios for Pyxis Oncology Inc (PYXS) - The Dwinnex

Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Pyxis Oncology to Participate in Two Upcoming Investor Conferences - StockTitan

JAZZ: 3 Oncology Stocks With Major Upside - StockNews.com

PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024 - MSN

Market Momentum Report: Pyxis Oncology Inc (PYXS)’s Positive Close at 3.62 - The Dwinnex

Q3 2024 EPS Estimates for Pyxis Oncology, Inc. Boosted by William Blair (NASDAQ:PYXS) - MarketBeat

What is the investor’s view on Pyxis Oncology Inc (PYXS)? - US Post News

Cetera Advisors LLC Makes New $100,000 Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Q3 2024 Earnings Estimate for Pyxis Oncology, Inc. (NASDAQ:PYXS) Issued By William Blair - Defense World

Vanguard Group Inc. Acquires 94,740 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Pyxis Oncology's (PYXS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com India

Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com

Market Insight: Pyxis Oncology Inc (PYXS)’s Notable Gain, Closing at 3.43 - The Dwinnex

Pyxis Oncology (NASDAQ:PYXS) Earns “Buy” Rating from HC Wainwright - Defense World

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - Marketscreener.com

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - StockTitan

Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00 - MarketBeat

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Pyxis Oncology stock gains as Stifel says buy (NASDAQ:PYXS) - Seeking Alpha

Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat

What was Pyxis Oncology Inc (PYXS)’s performance in the last session? - US Post News

Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - Defense World

Stifel sets $10 target on Pyxis Oncology, cites unique approach - Investing.com

Market Recap Check: Pyxis Oncology Inc (PYXS)’s Positive Finish at 3.37, Up/Down 3.69 - The Dwinnex

Pyxis Oncology Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$203m - Simply Wall St

Pyxis Oncology Inc (PYXS) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

SG Americas Securities LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - Marketscreener.com

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - StockTitan

July Breakout: Healthcare Biotechs In The Strongest Move Since November - Seeking Alpha

Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Update - MarketBeat

RBC Capital remains positive on Pyxis Oncology stock - Investing.com

Is Pyxis Oncology Inc (PYXS) positioned for future growth? - SETE News

Was Pyxis Oncology Inc (PYXS)’s session last reading good? - US Post News

Pyxis Oncology Inc (PYXS) Stock: A Year of Market Fluctuations - The InvestChronicle

Pyxis Oncology Inc (PYXS) stock analysis: A comprehensive overview - US Post News

Susquehanna Fundamental Investments LLC Invests $351,000 in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.80 Consensus Price Target from Analysts - MarketBeat

Did Pyxis Oncology Inc (PYXS) perform well in the last session? - US Post News

Analytical Overview: Pyxis Oncology Inc (PYXS)’s Ratios Tell a Financial Story - The Dwinnex

Nothing is Better Than Pyxis Oncology Inc (PYXS) stock at the moment - SETE News

Pyxis Oncology Inc (PYXS Stock: A Sea of Opportunity - The InvestChronicle

Pyxis Oncology Inc (PYXS) can make a big difference with a little luck - SETE News

A stock that deserves closer examination: Pyxis Oncology Inc (PYXS) – US Post News - US Post News

Market Momentum Report: Pyxis Oncology Inc (PYXS)'s Positive Close at 3.31 – DWinneX - The Dwinnex

A Pyxis Oncology, Inc. (NASDAQ:PYXS) insider increased their holdings last year - Yahoo Canada Sports

Pyxis Oncology reports inducement grants under Nasdaq listing rule - Medical Buyer

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

PYXS과 유사한 종목